{
  "author": "biocomputer",
  "original_created_utc": 1658762385,
  "title": "How significant are the recent revelations that some research related to amyloid beta plaques in Alzheimer’s disease may be fraudulent?",
  "created_utc": 1658787318,
  "selftext_html": "&lt;!-- SC_OFF --&gt;&lt;div class=\"md\"&gt;&lt;p&gt;The amyloid hypothesis of Alzheimer’s disease says that the accumulation of the peptide amyloid-β in the brain is the main cause of the disease. However, after decades of research and clinical trials there has been little to no success in treating Alzheimer&amp;#39;s patients based on this hypothesis, and it has been questioned, see for example:&lt;/p&gt;\n\n&lt;blockquote&gt;\n&lt;p&gt;&lt;a href=\"https://www.nature.com/articles/d41586-018-05719-4\"&gt;The amyloid hypothesis on trial. As the development of treatments for Alzheimer’s disease continues to stumble, is it time for researchers to broaden their list of the condition’s potential causes?\n&lt;/a&gt;&lt;/p&gt;\n&lt;/blockquote&gt;\n\n&lt;p&gt;It was recently reported that some western blot images which claim to show a sub-type of amyloid beta, Aβ*56, may have been manipulated. The report was the result of an investigation by &lt;em&gt;Science&lt;/em&gt;:&lt;/p&gt;\n\n&lt;blockquote&gt;\n&lt;p&gt;&lt;a href=\"https://www.science.org/content/article/potential-fabrication-research-images-threatens-key-theory-alzheimers-disease\"&gt;Blots on a field? A neuroscience image sleuth finds signs of fabrication in scores of Alzheimer’s articles, threatening a reigning theory of the disease&lt;/a&gt;&lt;/p&gt;\n&lt;/blockquote&gt;\n\n&lt;p&gt;Such manipulations the report claims go back to the original 2006 paper describing Aβ*56 in &lt;em&gt;Nature&lt;/em&gt;  written by Sylvain Lesné and Karen Ashe:&lt;/p&gt;\n\n&lt;blockquote&gt;\n&lt;p&gt;&lt;a href=\"https://www.nature.com/articles/nature04533\"&gt;A specific amyloid-β protein assembly in the brain impairs memory&lt;/a&gt;&lt;/p&gt;\n&lt;/blockquote&gt;\n\n&lt;p&gt;From the report in &lt;em&gt;Science&lt;/em&gt; one may get the impression that the vast majority of Aβ plaque-related research and drug development since then has been focused on the Aβ*56 subtype, in which case the alleged fraud would be an enormous setback to the field, with billions of dollars and decades of research time wasted. However, there are many types of Aβ and I&amp;#39;m unclear on just how important Aβ*56 is to the field of Alzheimer&amp;#39;s research and drug development. My initial thought was that there&amp;#39;s no way all this time, effort, and money has been invested in something that only one lab has published (even if they&amp;#39;ve published on it many times) and no independent researchers have validated. The &lt;em&gt;Science&lt;/em&gt; report says that some others have detected Aβ*56 but I don&amp;#39;t know in what context, or if this other work validates the work from Lesné and Ashe:&lt;/p&gt;\n\n&lt;blockquote&gt;\n&lt;p&gt;In the 16 years following the landmark paper, Lesné and Ashe—separately or jointly—published many articles on their stellar oligomer. Yet only a handful of other groups have reported detecting Aβ*56.&lt;/p&gt;\n&lt;/blockquote&gt;\n\n&lt;p&gt;An article on Alzforum has comments from some of the scientists involved in the controversy:&lt;/p&gt;\n\n&lt;blockquote&gt;\n&lt;p&gt;&lt;a href=\"https://www.alzforum.org/news/community-news/sylvain-lesne-who-found-av56-accused-image-manipulation\"&gt;Sylvain Lesné, Who Found Aβ*56, Accused of Image Manipulation&lt;/a&gt;&lt;/p&gt;\n&lt;/blockquote&gt;\n\n&lt;p&gt;In particular, the top comment which is from Karen Ashe, the senior author on the original 2006 paper:&lt;/p&gt;\n\n&lt;blockquote&gt;\n&lt;p&gt;...it is clear that there are two general forms of Aβ, type 1 and type 2. One particular form of type 1 (referred to in our papers as Aβ*56 and in the Science article as “toxic oligomers”) was shown by my lab and others to impair memory function in mice. The type 2 form of Aβ is the one found in amyloid plaques. It is this latter form that drug developers have repeatedly but unsuccessfully targeted. There have been no clinical trials targeting the type 1 form of Aβ...&lt;/p&gt;\n&lt;/blockquote&gt;\n\n&lt;p&gt;Scientific misconduct or fraud is of course terrible, and if true I&amp;#39;m sure this has set back at least some progress in the field. But just how significant is this fraud if it&amp;#39;s true?&lt;/p&gt;\n&lt;/div&gt;&lt;!-- SC_ON --&gt;",
  "score": 117,
  "permalink": "/r/askscience/comments/w7rmgo/how_significant_are_the_recent_revelations_that/",
  "subreddit": "askscience",
  "id": "w7rmgo",
  "is_self": true,
  "media": null,
  "is_video": false,
  "sensitive": false,
  "the_new_excerpt": "The amyloid hypothesis of Alzheimer’s disease says that the accumulation of the\npeptide amyloid-β in the brain is the main cause of the disease. However, after\ndecades of research and clinical trials there has been little to no success in\ntreating Alzheimer's patients based on this hypothesis, and…",
  "localize": [
    {
      "locale": "ja",
      "the_new_excerpt": "アルツハイマー病のアミロイド仮説では、蓄積された\nアミロイド仮説は、脳内のペプチドであるアミロイドβの蓄積が主な原因であるとするものである。しかし、その後\nしかし、数十年にわたる研究と臨床試験の結果、この病気の治療にはほとんど成功しませんでした。\nしかし、この仮説に基づいたアルツハイマー病患者の治療は、数十年にわたる研究・臨床試験の結果、ほとんど成功していません...",
      "title": "最近、アルツハイマー病のアミロイドβプラークに関する研究の一部が不正である可能性があることが明らかになりましたが、どのような意味があるのでしょうか？"
    },
    {
      "locale": "zh",
      "the_new_excerpt": "阿尔茨海默病的淀粉样蛋白假说说，积累的\n肽amyloid-β在大脑中的积累是该疾病的主要原因。然而，经过\n经过几十年的研究和临床试验，在治疗阿尔茨海默病方面几乎没有任何成功。\n基于这一假说治疗阿尔茨海默病患者几乎没有成功，而且...",
      "title": "最近披露的一些与阿尔茨海默病中的淀粉样β斑块有关的研究可能是欺诈性的，其意义如何？"
    },
    {
      "locale": "zh-Hant",
      "the_new_excerpt": "阿爾茨海默病的澱粉樣蛋白假說說，積累的\n肽amyloid-β在大腦中的積累是該疾病的主要原因。然而，經過\n經過幾十年的研究和臨牀試驗，在治療阿爾茨海默病方面幾乎沒有任何成功。\n基於這一假說治療阿爾茨海默病患者幾乎沒有成功，而且...",
      "title": "最近披露的一些與阿爾茨海默病中的澱粉樣β斑塊有關的研究可能是欺詐性的，其意義如何？"
    }
  ]
}